Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses

References

• Collaborators GAaDU. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987–1012.
   PubMed Web of Science ®Google Scholar
• Quality. CfBHSa. Results from the 2019 National Survey on Drug Use and Health: detailed tables; 2020. https://www.samhsa.gov/data/. Accessed October 29, 2020.
   Google Scholar
• Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
   PubMedGoogle Scholar
• Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80–86.
   PubMed Web of Science ®Google Scholar
• van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.
   PubMed Web of Science ®Google Scholar
• van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Healthcare professionals' regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services. Drug Alcohol Depend. 2014;134:92–98.
   PubMed Web of Science ®Google Scholar
• Sterk CE, Theall KP, Elifson KW. Health care utilization among drug-using and non-drug-using women. J Urban Health. 2002;79(4):586–599.
   PubMed Web of Science ®Google Scholar
• Partridge EE, Abu-Rustum N, Giuliano A, National Comprehensive Cancer Network, et al. Cervical cancer screening. J Natl Compr Canc Netw. 2014;12(3):333–341.
   PubMed Web of Science ®Google Scholar
• Group. USCSW. U.S. cancer statistics data visualizations tool, based on 2020 submission data (1999–2018); 2021. https://gis.cdc.gov/Cancer/USCS/#/Trends/. Accessed July 25, 2021.
   Google Scholar
• Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K. Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(10):698–705, W216.
   PubMed Web of Science ®Google Scholar
• Abrams MT, Myers CS, Feldman SM, et al. Cervical cancer screening and acute care visits among Medicaid enrollees with mental and substance use disorders. PS. 2012;63(8):815–822.
   Google Scholar
• Tilley D. Women with substance use under-screened for pap smears. Aust Nurs Midwifery J. 2013;21(3):50.
   PubMedGoogle Scholar
• Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002;252(3):206–224.
   PubMed Web of Science ®Google Scholar
• Kuper H, Adami HO, Boffetta P. Tobacco use, cancer causation and public health impact. J Intern Med. 2002;251(6):455–466.
   PubMed Web of Science ®Google Scholar
• Phillips AN, Smith GD. Cigarette smoking as a potential cause of cervical cancer: has confounding been controlled? Int J Epidemiol. 1994;23(1):42–49.
   PubMed Web of Science ®Google Scholar
• Ylitalo N, Sørensen P, Josefsson A, et al. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer. 1999;81(3):357–365/
   PubMed Web of Science ®Google Scholar
• Denny L, de Sanjose S, Mutebi M, et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet. 2016;389(10071).
   PubMed Web of Science ®Google Scholar
• Phelan DF, Gange SJ, Ahdieh-Grant L, et al. Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women. Sex Transm Dis. 2009;36(3):149–156.
   PubMed Web of Science ®Google Scholar
• Stover CT, Smith DK, Schmid DS, HIV Epidemiology Research Study Group, et al. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis. 2003;187(9):1388–1396.
   PubMed Web of Science ®Google Scholar
• Denny LA, Franceschi S, de Sanjosé S, Heard I, Moscicki AB, Palefsky J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine. 2012;30 (Suppl 5):F168–F174.
   PubMedGoogle Scholar
• Soccio J, Brown M, Comino E, Friesen E. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility. J Adv Nurs. 2015;71(12):2858–2866.
   PubMed Web of Science ®Google Scholar
• Reece A. Lifetime prevalence of cervical neoplasia in addicted and medical patients. Aust N Z J Obstet Gynaecol. 2007;47(5):419–423.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Guidelines for Screening and Treatment of Precancerous Lesions of Cervical Cancer Prevention. Geneva, Switzerland: World Health Organization; 2013.
   Google Scholar
• Control CfD. Cervical cancer. https://www.cdc.gov/cancer/cervical/. Accessed October 1, 2020.
   Google Scholar
• Lapham G, Boudreau DM, Johnson EA, PROUD Collaborative Investigators, et al. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020;207:107732.
   PubMed Web of Science ®Google Scholar
• Davis KA, Sudlow CL, Hotopf M. Can mental health diagnoses in administrative data be used for research? A systematic review of the accuracy of routinely collected diagnoses. BMC Psychiatry. 2016;16:263.
   PubMed Web of Science ®Google Scholar
• Lagisetty P, Garpestad C, Larkin A, et al. Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug Alcohol Depend. 2021;221:108583.
   PubMed Web of Science ®Google Scholar
• Paul DW, Neely NB, Clement M, et al. Development and validation of an electronic medical record (EMR)-based computed phenotype of HIV-1 infection. J Am Med Inform Assoc. 2018;25(2):150–157.
   PubMed Web of Science ®Google Scholar
• Stata. Version 15. Stata Corp LLC; 2018. http://www.stata.com/.
   Google Scholar
• Spithoff S, Kiran T, Khuu W, et al. Quality of primary care among individuals receiving treatment for opioid use disorder. Can Fam Physician. 05. 2019;65(5):343–351.
   PubMed Web of Science ®Google Scholar
• El-Bassel N, Gilbert L, Wu E, Go H, Hill J. HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med. 2005;61(1):171–183.
   PubMed Web of Science ®Google Scholar
• Owens L, Gilmore K, Terplan M, Prager S, Micks E. Providing reproductive health services for women who inject drugs: a pilot program. Harm Reduct J. 2020;17(1):47.
   PubMed Web of Science ®Google Scholar
• Association AP. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, Virginia: American Psychiatric Association; 2013.
   Google Scholar
• Palumbo SA, Adamson KM, Krishnamurthy S, et al. Assessment of probable opioid use disorder using electronic health record documentation. JAMA Netw Open. 2020;3(9):e2015909.
   PubMed Web of Science ®Google Scholar
• Howell BA, Abel EA, Park D, Edmond SN, Leisch LJ, Becker WC. Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a Chart Verification Study. J Gen Intern Med. 2021;36(5):1264–1270.
   PubMed Web of Science ®Google Scholar
• Hallgren KA, Witwer E, West I, et al. Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network. J Subst Abuse Treat. 2020;110:18–27.
   PubMed Web of Science ®Google Scholar